Expert insights. Personalized for you.
Pharma R&D Related Topics 
Pharma R&D Today
FEBRUARY 5, 2021
Along the way, scientists from these big pharma organizations rallied around their in-house data science experts and Elsevier consultants enabled these multidisciplinary teams to challenge each other and learn from one another. Pharma R&D API data science pandemic Reaxys upskilling
BioPharma Reporter
FEBRUARY 16, 2022
Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed. Markets & Regulations
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JUNE 1, 2021
According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.
Pharma Phorum
APRIL 5, 2022
For many years, those inside the pharma industry have been telling the same old story about innovation: pharma is big, slow, and risk averse. That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity.
Pharma Times
NOVEMBER 23, 2020
R&D spending in the sector last year represents an eight-year high
Outsourcing Pharma
JANUARY 14, 2022
According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.
Pharma Phorum
JUNE 16, 2021
Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. The post Transforming pharma R&D with a scientist-centric approach to AI & automation appeared first on.
BioTech 365
JANUARY 11, 2021
Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D ? Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ? … Continue reading → Business Wire
Elsevier
MAY 26, 2022
Chemistry Pharma R&D AI compounds Reaxys Reaxys User Day synthetic chemistryIn April, Elsevier hosted the first Reaxys User Day to learn from expert users and share best practices.
BioTech 365
DECEMBER 4, 2020
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months.Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months kblankenship Thu, 12/03/2020 – … Continue reading → #news
Elsevier
APRIL 26, 2022
AI & Data Chemistry Pharma R&D biological targets data science deep learning indexing models patent expansion patents Reaxys
BioTech 365
MAY 19, 2021
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science Funding for early- and late-stage R&D … Continue reading → Business Wire
BioTech 365
FEBRUARY 10, 2022
Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for … Continue reading → Business Wire
|
BioTech 365
AUGUST 11, 2020
First analytics dashboard tracking and visualizing data about AI-driven biotech startups and AI vendors in pharma space, supported by data aggregation engine LONDON & KYIV, Ukraine–(BUSINESS WIRE)–#artificialintelligence–BPT Analytics Ltd.
Elsevier
MAY 24, 2022
As discussed in a previous post, Pharma’s path to Net Zero , pharmaceutical operations are responsible for a significant amount of greenhouse gas emissions, driving many industry players to make Net Zero pledges.
Elsevier
MAY 3, 2022
Pharma is seldom top of mind when thinking about the most polluting industries, but pharmaceutical industry operations are in fact responsible for a significant portion of the world’s greenhouse gas emissions – even rivaling industries that are far more associated with contributing to the problem.
Elsevier
APRIL 5, 2022
Empowering Pharma to work better and faster. Her ChEMU collaboration is aimed at helping chemists and pharma companies do their work as efficiently and effectively as possible. Network.
Elsevier
MARCH 30, 2022
The Pistoia Alliance, an organization of over 100 companies (including Elsevier) that are committed to advancing R&D in the life sciences, has just launched a Women in STEM leadership pilot program that will involve several major players in pharma like Bayer, GSK, Merck, Roche, Pfizer and more.
Elsevier
JANUARY 11, 2022
COVID-19 Pharma R&D antiviral data Hepatitis C Pfizer protease inhibitor SARS-CoV-2
Pharma R&D Today
APRIL 28, 2022
There are life-changing insights waiting to be found in chemistry data. The critical information waiting to be unlocked can lead to incredible technology advances and medical breakthroughs. But there is so much data out there, and it is multiplying rapidly.
Elsevier
NOVEMBER 4, 2021
However, if you are not Big Pharma, it’s the how that slows down most LSH companies and organizations. AI & Data Pharma R&D AI data science digital transformation Embase Entellect life science data Reaxys
Pharma R&D Today
JUNE 14, 2022
But if you are working in big pharma with scaling in mind you may opt for greener options,” he explains.
Elsevier
OCTOBER 19, 2021
Pharma R&D data science pancreatitis Professional Services scientific literature text miningElsevier has just released the Emerging trends for pancreatitis in the scientific literature report, which identifies proteins and genes linked to pancreatitis.
Pharma R&D Today
JUNE 9, 2022
A consortium of 30+ pharma and biotech companies, phactMI is dedicated to delivering crucial and reliable drug information to the healthcare professionals when and where they need it.
Elsevier
AUGUST 12, 2021
AI & Data Chemistry Pharma R&D algorithms data Pending.AI In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting.
Pharma R&D Today
JUNE 1, 2022
One great initiative has been the establishment of the Pharma Collaboration for Transparent Medical Information (also known as phactMI ), a consortium of 30 pharmas that includes major companies like AstraZeneca, Bayer, Gilead, GSK, Merck, Pfizer and many more. “We
Pharma R&D Today
MAY 26, 2021
The Pharma Collaboration for Transparent Medical Information ( phactMI ) is a non-profit organization that seeks to improve the lives of patients by supporting the safe and effective use of medicines.
Pharma R&D Today
MARCH 2, 2021
The Pharma Collaboration for Transparent Medical Information ( phactMI ) is one such undertaking. Part 1: How healthcare professionals can access the latest and most accurate information on medications.
Pharma R&D Today
MARCH 31, 2021
This is the goal of the Pharma Collaboration for Transparent Medical Information ( phactMI ), a 501(c)(6) that seeks to improve the lives of patients through the safe and effective use of medicines.
Pharma R&D Today
MARCH 10, 2022
The pipeline has proven a game-changer in how pharma companies can now speedily track the competitive landscape – and be alerted to any threats to the long-term patentability of a particular discovery project. Umesh Nandal is a Director of Data Science at Elsevier.
Pharma R&D Today
SEPTEMBER 4, 2020
Figure 1. Classification of COVID-19 Disease States. Adapted from Sidiqi, H.K. and M.R. Mehra, COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transplant, 2020. [1]. This piece was co-authored by Prof.
Pharma R&D Today
APRIL 7, 2021
Pharma R&D access copyright compliance life sciences literature management Medical Affairs pharmacovigilance practices reference management scientific literature
Pharma R&D Today
JANUARY 18, 2022
“Yes. I was amazed by the Reaxys Predictive Retrosynthesis technology,” says Moritz Classen of the Carreira Research Group at ETH Zurich. He and his colleagues spent months evaluating the tool as they applied it into their daily workflows. “It’s
Pharma R&D Today
FEBRUARY 19, 2021
Pharma R&D 2021 coronavirus COVID-19 drug repurposing genomics personalized medicine phactMI predictive tools QUOSA Reaxys therapeutics vaccines
Pharma R&D Today
MAY 7, 2021
In a day dedicated to emerging science and technologies at the Pistoia Alliance virtual conference Collaborative R&D in Action , SciBite CTO James Malone opened the program with a compelling exploration of use cases for semantic-based machine learning (ML).
Pharma R&D Today
DECEMBER 2, 2021
Mark Sheehan is VP Data Science on Elsevier’s Life Science team. His 20 years at the company maps closely with Elsevier’s digital journey over that time. And today, pharmaceutical companies can follow a similar journey – albeit highly accelerated – using Elsevier’s latest AI-driven R&D boosters.
Pharma R&D Today
NOVEMBER 17, 2021
Your AI applications are only as strong as your data. This is why Elsevier strives to make data not only align with FAIR usability principles but also be maximized for trustworthiness and relevance.
Pharma R&D Today
NOVEMBER 11, 2021
We talk a lot about how innovation is driven by technological advances such as AI and machine learning – but equally important to innovation are partnerships and collaborations.
Pharma R&D Today
JULY 29, 2021
Pharma R&D coronavirus COVID-19 Reaxys remote working Research work from home working remotelyWe at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this recent Comparably article.
Pharma R&D Today
OCTOBER 5, 2021
Currently, the Pharma Collaboration for Transparent Medical Information (phactMI) is providing one such source for evidence-based drug information via the powerful Entellect platform.
Pharma R&D Today
SEPTEMBER 20, 2021
AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases.
Pharma R&D Today
NOVEMBER 16, 2020
Wasting no time to start enacting his forthcoming administration’s plan for tackling COVID-19, new president-elect of the United States, Joe Biden, has unveiled his coronavirus advisory team.
Pharma R&D Today
SEPTEMBER 8, 2021
Indisputably, a surge in predictive machine learning models to support synthetic chemistry has galvanized a movement to make these tools effective R&D solutions. Reaxys has been part of this innovation journey from the beginning.
52 
Let's personalize your content